Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ENDP - Endo: FDA Approves Generic Form Of Vasostrict Creating Headwind Into Next Year

ENDP - Endo: FDA Approves Generic Form Of Vasostrict Creating Headwind Into Next Year

Endo International plc
  • Eagle Pharmaceuticals receives FDA approval to sell a generic form of vasopressin, a competitor to ENDP's Vasostrict.
  • This approval follows Eagle's courtroom win in a patent dispute with Endo several months ago.
  • Vasostrict is Endo's biggest revenue source, responsible for $786 million of high margin sales last year.
  • Eagle expects 180-day marketing exclusivity for vasopressin.
  • Continue to see the stock as high risk.

For further details see:

Endo: FDA Approves Generic Form Of Vasostrict Creating Headwind Into Next Year
Stock Information
Company Name: Endo International plc
Stock Symbol: ENDP
Market: NASDAQ
Website: endo.com
Menu
ENDP ENDP Quote ENDP Short ENDP News ENDP Articles ENDP Message Board
Get ENDP Alerts

News, Short Squeeze, Breakout and More Instantly...